DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170374

A study of peripartum cardiomyopathy in a tertiary care center in India

Aditi V. Joshi, Michelle N. Fonseca, Deepali S. Kharat-Kapote

Abstract


Background: Peripartum cardiomyopathy is an idiopathic and reversible form of dilated cardiomyopathy. The aim of the study was to study the mean age of presentation of peripartum cardiomyopathy in pregnant patients over a period of 1 year in a tertiary health care and study the maternal and fetal outcome of patients with peripartum cardiomyopathy.

Methods: A retrospective observational study with total of 22 patients with peripartum cardiomyopathy was diagnosed in a total of 10,279 deliveries conducted at LTMMC, Sion hospital between September 2014 to February 2016.

Results: Our study revealed that most of the affected patients were young with the mean age at presentation being 26.8±4.29 years. Most of the patients were diagnosed in the postpartum period (63.6%). the most common risk factor was pre-eclampsia (22.7%) followed by anemia (18.2%). The mean Ejection fraction at the time of presentation was 25.3±9.8%. There were 2 (9.1%) intrauterine fetal deaths and 1 neonatal death.

Conclusions: There is a need for more multi-centric studies in order to understand the underlying pathogenesis and to determine the possible early interventions to help provide better pregnancy outcome.

Keywords


Induction of labour, Prolonged pregnancy, Perinatal morbidity, Ultrasound

Full Text:

PDF

References


Fennira S, Demiraj A, Khouaja A, Boujnah MR. Peripartum cardiomyopathy. Annales de Cardiologie et D’angéiologie. 2006;55(5):271-5.

Pandit V, Shetty S, Kumar A. Incidence and out come ofperipartum Cardiomyopathy from a tertiary hospitalin South India.Trop Doct. 2009;39:168-9.

Pearson GD, Veille JC, Rahimttola S. PeripartumCardiomyopathy; National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institute of Health) workshoprecommendation and review. JAMA. 2000;283:1183-88.

Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050.

Sliwa K, Hilfiker-Kleiner D, Petrie MC. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure, 12(8), 767–78.

Sarojini A, Sai Ravi Shanker A, Anitha, M. Inflammatory Markers-Serum Level of C-Reactive Protein, Tumor Necrotic Factor-α, and Interleukin-6 as Predictors of Outcome for Peripartum Cardiomyopathy. Journal of Obstetrics and Gynaecology of India. 2013;63(4):234-9.

Bhattacharyya A, Basra SS, Sen P. Peripartum cardiomyopathy: a review. Texas Heart Institute Journal/from the Texas Heart Institute of St. Luke’s Episcopal Hospital, Texas Children's Hospital. 2012;39(1):8-16.

Mishra VN, Mishra, N, Devanshi. Peripartum cardiomyopathy. The Journal of the Association of Physicians of India. 2013;61(4):268-73.

Davis M, Duvernoy C. Peripartum cardiomyopathy: current knowledge and future directions. Women’s Health (London, England). 2015;11(4):565-73.

Peripartum Cardiomyopathy: A Current Review KatieM. Twomley and Gretchen L.Wells: Hindawi Publishing Corporation Journal of Pregnancy. 2010; Article ID 149127.

Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-78.